Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Evaluating traditional loans versus credit builder options helps you determine the best path for credit growth based on your situation.
25,423 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A surprise shift in BOJ policy sent traders scrambling, triggering large outflows from U.S. spot Bitcoin ETFs and eye...
A new energy setback from the Iran conflict is reverberating worldwide. Global flows are disrupted, prices move, and ...
Analysts trimmed Home Depot price targets after the retailer's Q1 results, signaling a cyclical pause rather than a l...
A noted economist who studied sports money foresees a record run for FIFA, with 2026 ticket receipts pushing revenue ...
Dell Technologies beats expectations, validating its AI-focused partnership with Palantir and sending Palantir shares...
IBM shares surged as a resurfaced media clip spotlighted the company’s leadership while federal backing for quantum r...
A late-night visit to a KC custard shop turned into a generous moment that sparked a bigger conversation about tippin...
New on-chain data points to activity investor capitulation extremes for XRP, with profitability shrinking and transac...
SpaceX's public debut ignites a rapid sector rotation out of listed space stocks. Virgin Galactic craters 24% as inve...
A prominent wall street analyst calls for a bull-case ascent to 9,000 for the S&P 500, citing steady policy and impro...
A daring forecast from Goldman Sachs imagines SpaceX turning into a multi-hundred-billion-dollar revenue machine by 2...